L-3,4-dihydroxyphenylalanine (L-dopa) as an inhibitor of prolactin release.
D000818:Animals; D002230:Carbidopa / Q000494:pharmacology; D002369:Castration; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D007980:Levodopa / Q000494:pharmacology*; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D051381:Rats; D013363:Submandibular Gland / Q000378:metabolism
D007980:Levodopa; D011388:Prolactin; D007986:Luteinizing Hormone; D002230:Carbidopa; D004298:Dopamine; D009638:Norepinephrine